arrow_back Back to App

Expanded Research and Education for Endometrial Cancer

This act aims to boost research into endometrial cancer and enhance public education on the topic. It focuses on reducing disparities in diagnosis and treatment, especially among African-American women, potentially leading to better health outcomes and increased public awareness.
Key points
Increased funding for endometrial cancer research, including studies on disparities in incidence and mortality.
Establishment of public education programs, specifically targeting African-American women, about symptoms, risk factors, and available treatments.
Requirement for clinical trials on endometrial cancer to include African-American women participants to ensure representativeness and treatment effectiveness for all groups.
Coordination among various public health institutions to streamline research and educational efforts.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_10439
Sponsor: Rep. Scott, David [D-GA-13]
Process start date: 2024-12-16
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Endometrial Cancer Research and Education Act of 2024

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_10439.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-12-16.

What are the main provisions?

Key points include:

  • Increased funding for endometrial cancer research, including studies on disparities in incidence and mortality.
  • Establishment of public education programs, specifically targeting African-American women, about symptoms, risk factors, and available treatments.
  • Requirement for clinical trials on endometrial cancer to include African-American women participants to ensure representativeness and treatment effectiveness for all groups.
  • Coordination among various public health institutions to streamline research and educational efforts.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Scott, David [D-GA-13].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health